Fall Recognition Based on an IMU Wearable Device and Fall Verification through a Smart Speaker and the IoT.

A fall is one of the most devastating events that aging people can experience. Fall-related physical injuries, hospital admission, or even mortality among the elderly are all critical health issues. As the population continues to age worldwide, there is an imperative need to develop fall detection systems. We propose a system for the recognition and verification of falls based on a chest-worn wearable device, which can be used for elderly health institutions or home care. The wearable device utilizes a built-in three-axis accelerometer and gyroscope in the nine-axis inertial sensor to determine the user's postures, such as standing, sitting, and lying down. The resultant force was obtained by calculation with three-axis acceleration. Integration of three-axis acceleration and a three-axis gyroscope can obtain a pitch angle through the gradient descent algorithm. The height value was converted from a barometer. Integration of the pitch angle with the height value can determine the behavior state including sitting down, standing up, walking, lying down, and falling. In our study, we can clearly determine the direction of the fall. Acceleration changes during the fall can determine the force of the impact. Furthermore, with the IoT (Internet of Things) and smart speakers, we can verify whether the user has fallen by asking from smart speakers. In this study, posture determination is operated directly on the wearable device through the state machine. The ability to recognize and report a fall event in real-time can help to lessen the response time of a caregiver. The family members or care provider monitor, in real-time, the user's current posture via a mobile device app or internet webpage. All collected data supports subsequent medical evaluation and further intervention.

Integration of on-chip perovskite nanocrystal laser and long-range surface plasmon polariton waveguide with etching-free process.

Perovskite materials prepared in the form of solution-processed nanocrystals and used in top-down fabrication techniques are very attractive to develop low-cost and high-quality integrated optoelectronic circuits. Particularly, integrated miniaturized coherent light sources that can be connected to light-guiding structures on a chip are highly desired. To control light propagating on a small footprint with low-loss optical modes, long-range surface plasmon polariton (LRSPP) waveguides are employed. Herein, we demonstrate an on-chip fabricated photonic-plasmonic hybrid system consisting of a perovskite lasing structure coupled to an LRSPP waveguide achieving a low lasing threshold and a propagation length over 100 µm. Preventing perovskite material degradation and the formation of surface roughness of the laser cavity during fabrication is made possible by designing a fabrication technique without any etching step.

A Stimulated Mixed Micelle System for In Vitro Study on Chemo-Photodynamic Therapy.

A mixed micelle system with pH-responsive and photoactive zinc tetra(progaryloxy-phenyl) porphyrin (ZnTPP) core is constructed for encapsulation of doxorubicin (DOX) to facilitate combined chemo-photodynamic therapy in one delivery system. The mixed micelles show low critical micelle concentration, good storage stability, a pH dependent behavior, and better singlet oxygen generation efficiency compared to the star-shaped PEG-ZnTPP micelles, where the aggregation of ZnTPP within the core, resulting in less photoactive effect. The cell viability treated with DOX-loaded mixed micelles shows higher cytotoxicity than single drug loaded micelles under light irradiation. The improved therapeutic efficiency indicates the combined effect of DOX and ZnTPP and this mixed micelle system has potential as dual-modality for cancer treatment.

Hemolysis-induced acute kidney injury following cardiac surgery: a case report and review of the literature.

Acute kidney injury is a common complication following cardiac surgery. Even small increases in creatinine levels are associated with increases in morbidity and mortality. Numerous factors such as hemolysis can contribute to the development of acute kidney injury after cardiac surgery. We present a rare case of severe hemolysis related to cardiopulmonary bypass resulting in kidney injury and requiring dialysis. The patient's renal function gradually recovered when hemolysis was improved. After follow-up for 3 months, his creatinine levels returned to normal. We discussed the pathogenesis of this hemolysis-related kidney dysfunction, the causes of hemolysis during cardiac surgery, and a new treatment option.

Multiorgan failure following mass wasp stings.

Wasp bites usually bring temporary discomfort and pain, but on occasion, they can cause serious infections and fatal allergic reactions. We report on a patient who experienced massive wasp stings and developed multiple organ failure, including acute kidney, hepatic failure, and circulatory collapse 4 days later. He was treated with aggressive fluid resuscitation, inotropic agent, intravenous injection of steroids, broad-spectrum antibiotics, and hemodialysis. After intensive treatment, his liver function recovered one month later. Recovery of renal function was delayed, and the patient needed temporary regular hemodialysis. The pathology of kidney biopsy showed acute tubulointerstitial nephritis. This case shows that toxic reactions following massive wasp attacks may happen several days after the fact and result in severe, multiorgan system dysfunction.

Comparison of parenteral iron sucrose and ferric chloride during erythropoietin therapy of haemodialysis patients.

AIM: To compare the effects of i.v. iron sucrose and Fe chloride on the iron indices of haemodialysis patients with anaemia. METHODS: One hundred and eight haemodialysis patients receiving recombinant human erythropoiesis-stimulating agent (ESA) (mean age 59.37 years) were enrolled and randomly assigned to an iron sucrose or an Fe chloride group. Iron supplements were administered at 100 mg/week during the first 4 weeks (loading dose). Ferritin and transferrin saturation (TSAT) were then measured and dose adjusted. Ninety-eight subjects completed treatment; 51 in the iron sucrose group and 47 in the Fe chloride group. Ferritin, TSAT, haematocrit (Hct), reticulocyte count, serum albumin, fractional clearance of urea (Kt/V) and intact parathyroid hormone (iPTH) were measured. RESULTS: There was no significant difference in baseline characteristics between the groups. Significant differences between the groups were observed in both iron indices and ESA dosage. Hct at week 24 (31.1% vs 29.7%, P = 0.006) and ferritin at week 20 (731.3 vs 631.7 ng/mL, P = 0.006) in the iron sucrose group were significantly higher than in the Fe chloride group. ESA dosage used in the iron sucrose group at week 8 was significantly lower than in the Fe chloride group (244.9 vs 322.6 U/kg per month, P = 0.003), and iron sucrose group received significantly lower iron dose than the Fe chloride group at week 8 (P = 0.005). CONCLUSION: Although the differences in ESA dosage, ferritin and iron dosage between two groups were found during the study period while similar results were shown at the end of 24 week study. Thus, iron sucrose and Fe chloride are safe and work equally well for haemodialysis patients.